CTC Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,100
Closed -$469K 187
2022
Q3
$469K Buy
+3,100
New +$469K 0.38% 63